Patents by Inventor Wanli Smith

Wanli Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
    Patent number: 9701627
    Abstract: Compounds, and methods of using the same, are provided as therapies for the treatment leucine-rich repeat kinase-2 (LRRK2)-related disorders including, but not limited to, neurodegenerative and neuroinflammatory disorders, such as Parkinson's Disease.
    Type: Grant
    Filed: June 16, 2015
    Date of Patent: July 11, 2017
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Wanli Smith, Fengtian Xue, Alexander D MacKerell, Jr.
  • LRRK2 GTP BINDING INHIBITORS FOR TREATMENT OF PARKINSON'S DISEASE AND NEUROINFLAMMATORY DISORDERS
    Publication number: 20150361038
    Abstract: Compounds, and methods of using the same, are provided as therapies for the treatment leucine-rich repeat kinase-2 (LRRK2)-related disorders including, but not limited to, neurodegenerative and neuroinflammatory disorders, such as Parkinson's Disease.
    Type: Application
    Filed: June 16, 2015
    Publication date: December 17, 2015
    Inventors: Wanli Smith, Fengtian Xue, Alexander D. MacKerell, JR.